These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4947933)

  • 1. [Use of Peritrate in acute coronary insufficiency].
    Tricot R; Valère P; Castillo A
    Therapeutique; 1971 Nov; 47(9):777-8. PubMed ID: 4947933
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrolyte therapy of coronary insufficiency in the practice].
    Menzel M
    Landarzt; 1968 Jul; 44(20):993-5. PubMed ID: 5717732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical results of the use of a new drug association in heart diseases].
    Chierici F; Artuso P; Suriani L
    Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic possibilities in coronary disease].
    Zoli I; Baroncini S; Cornia GL; Donato S; Minore G; Pigini G; Pretolani E
    Minerva Med; 1973 Nov; 64(84):4445-57. PubMed ID: 4272415
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hemodynamic profile of pentaerythrityl tetranitrate].
    Engelmann L; Gottschild D
    Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies with a new anticoronaritis preparation].
    Amadini S; Bagnoli L
    Minerva Cardioangiol; 1969 Aug; 17(8):532-48. PubMed ID: 5402252
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 13. [The drug therapy effect on functional and organic stenocardias].
    Gill E
    Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical testing of a new combination product of a beta blocking agent and a nitroderivative].
    Melli A; Malagù I; Golinelli G; Soffritti A
    Minerva Med; 1970 Sep; 61(78):4271-8. PubMed ID: 4397054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
    Di Prisco AU; Vaccari GL; Soro A; Mora A
    Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Peritrate life-sustaining?
    Med Lett Drugs Ther; 1966 Jan; 8(2):5-7. PubMed ID: 5324990
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.